A panel of novel biomarkers representing different disease pathways improves prediction of renal function decline in type 2 diabetes.
<h4>Objective</h4>We aimed to identify a novel panel of biomarkers predicting renal function decline in type 2 diabetes, using biomarkers representing different disease pathways speculated to contribute to the progression of diabetic nephropathy.<h4>Research design and methods</...
Main Authors: | Michelle J Pena, Andreas Heinzel, Georg Heinze, Alaa Alkhalaf, Stephan J L Bakker, Tri Q Nguyen, Roel Goldschmeding, Henk J G Bilo, Paul Perco, Bernd Mayer, Dick de Zeeuw, Hiddo J Lambers Heerspink |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0120995 |
Similar Items
-
The geographical distribution of leadership in globalized clinical trials.
by: Jarno Hoekman, et al.
Published: (2012-01-01) -
Multimarker Panels in Diabetic Kidney Disease: The Way to Improved Clinical Trial Design and Clinical Practice?
by: Paul Perco, et al.
Published: (2019-02-01) -
The use of surrogate endpoints in regulating medicines for cardio-renal disease: opinions of stakeholders.
by: Bauke Schievink, et al.
Published: (2014-01-01) -
How to measure and monitor albuminuria in healthy toddlers?
by: Sophie Marielle van den Belt, et al.
Published: (2018-01-01) -
A novel drug response score more accurately predicts renoprotective drug effects than existing renal risk scores
by: Nienke M. A. Idzerda, et al.
Published: (2021-02-01)